Establishment Labs Holdings Inc. (NASDAQ:ESTA) Given Average Rating of “Moderate Buy” by Brokerages

Establishment Labs Holdings Inc. (NASDAQ:ESTA) has earned a consensus recommendation of “Moderate Buy” from the five brokerages that are currently covering the company, MarketBeat reports. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company. The average 12-month target price among brokers that have issued a report on the stock in the last year is $55.80.

A number of research analysts have weighed in on the company. Needham & Company LLC restated a “buy” rating and issued a $48.00 price objective on shares of Establishment Labs in a report on Friday, June 13th. Wall Street Zen lowered Establishment Labs from a “hold” rating to a “sell” rating in a report on Saturday. BTIG Research assumed coverage on Establishment Labs in a report on Friday, May 16th. They issued a “buy” rating and a $62.00 price objective on the stock. Mizuho raised their price objective on Establishment Labs from $58.00 to $70.00 and gave the company an “outperform” rating in a report on Wednesday, July 16th. Finally, Citigroup raised their price objective on Establishment Labs from $38.00 to $47.00 and gave the company a “neutral” rating in a report on Wednesday, July 9th.

Institutional Trading of Establishment Labs

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Geode Capital Management LLC increased its stake in shares of Establishment Labs by 1.2% in the 2nd quarter. Geode Capital Management LLC now owns 25,917 shares of the company’s stock worth $1,105,000 after acquiring an additional 299 shares during the last quarter. Patriot Financial Group Insurance Agency LLC increased its stake in shares of Establishment Labs by 5.2% in the 2nd quarter. Patriot Financial Group Insurance Agency LLC now owns 6,025 shares of the company’s stock worth $257,000 after acquiring an additional 300 shares during the last quarter. Raymond James Financial Inc. increased its stake in shares of Establishment Labs by 0.4% in the 1st quarter. Raymond James Financial Inc. now owns 119,752 shares of the company’s stock worth $4,886,000 after acquiring an additional 491 shares during the last quarter. Swiss National Bank increased its stake in shares of Establishment Labs by 1.3% in the 1st quarter. Swiss National Bank now owns 39,000 shares of the company’s stock worth $1,591,000 after acquiring an additional 500 shares during the last quarter. Finally, Quarry LP acquired a new stake in shares of Establishment Labs in the 4th quarter worth $27,000. 72.91% of the stock is owned by institutional investors and hedge funds.

Establishment Labs Trading Up 1.0%

Shares of ESTA opened at $38.32 on Friday. Establishment Labs has a fifty-two week low of $26.56 and a fifty-two week high of $50.85. The stock has a market capitalization of $1.11 billion, a PE ratio of -12.56 and a beta of 0.83. The company has a debt-to-equity ratio of 9.71, a quick ratio of 1.67 and a current ratio of 2.84. The company’s fifty day moving average is $40.78 and its 200 day moving average is $37.08.

Establishment Labs (NASDAQ:ESTA) last announced its earnings results on Thursday, August 7th. The company reported ($0.57) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.54) by ($0.03). Establishment Labs had a negative net margin of 49.89% and a negative return on equity of 224.34%. The business had revenue of $51.30 million for the quarter, compared to analysts’ expectations of $50.80 million. During the same quarter last year, the business earned ($0.62) EPS. The company’s quarterly revenue was up 16.1% on a year-over-year basis. Sell-side analysts expect that Establishment Labs will post -2.41 earnings per share for the current fiscal year.

Establishment Labs Company Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.